UPMC Hamot 2020 Neuroscience Conference: Rapidly Progressing Dementias - What You Need to Know

This presentation was part of the UPMC Hamot 2020 Neuroscience Conference and was designed to meet requirements for Stroke credit.

Target Audience

Primary care physicians, internists, neurologists, neurosurgeons, nurses, nurse practitioners, physician assistants; physical, occupational, and speech therapists; and other advanced practice providers will benefit from this activity.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Identify types of rapidly progressing dementia
  • Describe assessment and differential diagnosis for rapidly progressing dementia
  • Assess treatment options for rapidly progressing dementia
 
 
 
 

Suggested Additional Reading

  1. Caine, D., Tinelli, R. J., Hyare, H., Vita, E. D., Lowe, J., Lukic, A., et al.(2015). The cognitive profile of prion disease: A prospective clinical and imaging study. Annals of Clinical and Translational Neurology, 2(5), 548-558. doi:10.1002/acn3.195
  2. Creutzfeldt-Jakob disease. (2018, October 04). Retrieved from https://www.mayoclinic.org/diseases-conditions/creutzfeldt-jakob-disease/symptomscauses/syc-20371226
  3. Creutzfeldt-Jakob Disease, Classic (CJD). (2018, October 09). Retrieved from https://www.cdc.gov/prions/cjd/index.html
  4. Geschwind, M. D. (2016). Rapidly Progressive Dementia. CONTINUUM: Lifelong Learning in Neurology, 22(2, Dementia), 510-537. doi:10.1212/con.0000000000000319
  5. Geschwind, M. D., Haman, A., & Miller, B. L. (2007). Rapidly Progressive Dementia. Neurologic Clinics, 25(3), 783-807. doi:10.1016/j.ncl.2007.04.001
  6. Geschwind, M. D., Shu, H., Haman, A., Sejvar, J. J., & Miller, B. L. (2008). Rapidly progressive dementia. Annals of Neurology, 64(1), 97-108. doi:10.1002/ana.21430
  7. Iwasaki, Y. (2016). Creutzfeldt-Jakob disease. Neuropathology, 37(2), 174-188. doi:10.1111/neup.12355 Neuroanatomy through clinical cases. 2nd edition. 2010.. Sunderland, Mass.: Sinauer Associates.
  8. Paterson, R. W., Takada, L. T., & Geschwind, M. D. (2012). Diagnosis and treatment of rapidly progressive dementias. Neurology: Clinical Practice, 2(3), 187-200. doi:10.1212/cpj.0b013e31826b2ae8

 

 
Course summary
Available credit: 
  • 0.75 AAPA Category I CME
  • 0.75 AMA PRA Category 1 Credit™
    The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
  • 0.75 ANCC
    UPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
  • 0.75 Attendance
Course opens: 
02/15/2021
Course expires: 
02/15/2024
UPMC Hamot Online Learning
United States

Presenter:

  • Nykole Gonzalez, PsyD, Postdoctoral Fellow, Northshore Neuroscience

    Planning Committee Members:

    1. Haylee Esposito, UPMC Hamot
    2. Tammy Kordes, PhD, Neuropsychologist, Northshore Neurosciences
    3. Debbie Morton, BSN, RN, NPD-BC
    4. Samantha Panighetti, MOT, OTR/L, NTMTC, UPMC Hamot
    5. Rebecca Parkhurst, PA-C, UPMC Hamot
    6. Trevor Phinney, DO, UPMC Northshore Neurology
    7. Margaret Pett, UPMC Hamot
    8. Ann Sokoloff, BSN, CNRN, Clinical Director, Ortho/Neuro Services, UPMC Hamot
    9. Stacy Wing, PT, UPMC Hamot

    No relationships with industry relevant to the content of this educational activity have been disclosed.

    Authors disclosure of relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients is listed above. No other planners, members of the planning committee, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.

     
     
     
     
     
     
     
 
 
 
 
 

In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The University of Pittsburgh School of Medicine designates this enduring material for a maximum of .75 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The University of Pittsburgh has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for .75 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

The maximum number of hours awarded for this Continuing Nursing Education activity is .75 contact hours.

Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.

All presenters disclosure of relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients is listed above.  No other planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.

 
 
 
 
 
 
 
 
 
 
 

Available Credit

  • 0.75 AAPA Category I CME
  • 0.75 AMA PRA Category 1 Credit™
    The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
  • 0.75 ANCC
    UPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
  • 0.75 Attendance
Please login or register to take this course.